Atlas Trials

Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor

Clinical trial NCT00049127 · COMPLETED

Trial details

NCT number
NCT00049127
Sponsor
Alliance for Clinical Trials in Oncology
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Adult Anaplastic OligodendrogliomaAdult Mixed GliomaAdult OligodendrogliomaRecurrent Adult Brain Neoplasm
Start date
2003-06-01
Primary completion
2011-08-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.